1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease Evidence from the SFA-Long Study

JACC: Cardiovascular Interventions

Volumn 9, Issue 9, 2016, Pages 950-956

  Micari, Antonio ^a   Vadalà, Giuseppe ^a   Castriota, Fausto ^b   Liso, Armando ^c   Grattoni, Chiara ^b   Russo, Paolo ^d   Marchese, Alfredo ^e   Pantaleo, Paolo ^f   Roscitano, Giuseppe ^a   Cesana, Bruno Mario ^g   Cremonesi, Alberto ^b  

^a Maria Eleonora Hospital   (Italy)

^b MARIA CECILIA HOSPITAL   (Italy)

^c Citta di Lecce Hospital   (Italy)

^d Villa Maria Pia Hospital   (Italy)

^e Anthea Hospital   (Italy)

^f Gruppo Villa Maria Care and Research   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

Author keywords

paclitaxel coated balloon; percutaneous transluminal angioplasty; peripheral artery disease

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT;

ABSENCE OF SIDE EFFECTS; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BALLOON; BRAIN INFARCTION; CAUSE OF DEATH; DISEASE SEVERITY; FEMALE; FEMOROPOPLITEAL ARTERY DISEASE; FOLLOW UP; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NITINOL STENT; OUTCOME ASSESSMENT; PACLITAXEL COATED BALLOON; PATIENT SAFETY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; CLINICAL TRIAL; DEVICES; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; FEMORAL ARTERY; ITALY; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VASCULAR CALCIFICATION; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON; ANKLE BRACHIAL INDEX; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; ITALY; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR CALCIFICATION; VASCULAR PATENCY;

EID: 84965108553     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.02.014     Document Type: Article

References (21)

1. D.J. Adam, J.D. Beard, T. Cleveland, and et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934
2. G. Biondi-Zoccai, G. Sangiorgi, and M.G. Modena Devices for infrainguinal endovascular therapy: menu a la carte or table d'hote? J Endovasc Ther 18 2011 638 641
3. G. Sangiorgi, G. Lauria, F. Airoldi, and et al. Retrograde popliteal access as bail-out strategy for challenging occlusions of the superficial femoral artery: a multicenter registry Catheter Cardiovasc Interv 79 2012 1188 1193
4. M. Werk, S. Langner, B. Reinkensmeier, and et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
5. G. Tepe, T. Zeller, T. Albrecht, and et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
6. A. Micari, A. Cioppa, G. Vadala, and et al. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results EuroIntervention 7 Suppl K 2011 K77 K82
7. A. Micari, A. Cioppa, G. Vadala, and et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry J Am Coll Cardiol Intv 5 2012 331 338
8. M.M. McDermott, K. Liu, J.M. Guralnik, G.J. Martin, M.H. Criqui, and P. Greenland Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease J Vasc Surg 28 1998 1072 1081
9. EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life Health Policy 16 1990 199 208
10. M. Schillinger, S. Sabeti, C. Loewe, and et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
11. J.R. Laird, B.T. Katzen, D. Scheinert, and et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial J Endovasc Ther 19 2012 1 9
12. M. Schillinger, S. Sabeti, P. Dick, and et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting Circulation 115 2007 2745 2749
13. J.S. Matsumura, D. Yamanouchi, J.A. Goldstein, and et al. The United States Study for Evaluating Endovascular Treatments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By Using the Protege Everflex Nitinol Stent System II (DURABILITY II) J Vasc Surg 58 2013 73 83
14. L. Garcia, M.R. Jaff, C. Metzger, and et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial Circ Cardiovasc Interv 8 2015 e000937
15. W.A. Gray, A. Feiring, M. Cioppi, and et al. S.M.A.R.T. Self-Expanding Nitinol Stent for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (STROLL): 1-year outcomes J Vasc Interv Radiol 26 2015 21 28
16. M. Bosiers, K. Deloose, J. Callaert, and et al. Results of the Protege EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions J Vasc Surg 54 2011 1042 1050
17. E.J. Armstrong, H. Saeed, B. Alvandi, and et al. Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions J Endovasc Ther 21 2014 34 43
18. A. Tosaka, Y. Soga, O. Iida, and et al. Classification and clinical impact of restenosis after femoropopliteal stenting J Am Coll Cardiol 59 2012 16 23
19. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
20. M.D. Dake, D. Scheinert, G. Tepe, and et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study J Endovasc Ther 18 2011 613 623
21. T. Zeller, A. Rastan, R. Macharzina, and et al. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions J Endovasc Ther 21 2014 359 368